Clinical Hypertension

Scope & Guideline

Connecting global minds to combat hypertension.

Introduction

Explore the comprehensive scope of Clinical Hypertension through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Clinical Hypertension in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherSPRINGERNATURE
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCLIN HYPERTENS / Clin. Hypertens.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Clinical Hypertension' primarily focuses on advancing the understanding and management of hypertension and its associated health complications. It encompasses a broad range of research methodologies, including clinical trials, observational studies, systematic reviews, and meta-analyses, aiming to provide comprehensive insights into hypertension-related issues.
  1. Clinical Management of Hypertension:
    This area examines various interventions, treatments, and management strategies for hypertension, including pharmacological therapies, lifestyle modifications, and novel approaches such as the use of artificial intelligence.
  2. Epidemiological Studies:
    Research focusing on the prevalence, risk factors, and outcomes associated with hypertension in different populations, including children, adolescents, and specific demographic groups.
  3. Pathophysiological Mechanisms:
    Exploration of the biological and physiological mechanisms underlying hypertension, including genetic, metabolic, and environmental factors.
  4. Guideline Development and Implementation:
    The journal publishes updates and consensus documents related to clinical guidelines for hypertension diagnosis and treatment, reflecting best practices and evidence-based recommendations.
  5. Innovative Measurement Techniques:
    Investigation into new methods for measuring blood pressure, including the use of ambulatory monitoring and cuffless devices, to improve accuracy and patient adherence.
The landscape of hypertension research is continually evolving, with several emerging themes gaining traction in recent publications of 'Clinical Hypertension.' This section outlines the latest trends and their significance for future research and clinical practice.
  1. Hypertension in Special Populations:
    There is a growing focus on understanding hypertension in specific groups such as children, adolescents, women during pregnancy, and populations with unique health challenges.
  2. Integration of Technology in Hypertension Management:
    Research exploring the use of wearable devices and telemedicine for hypertension monitoring and management is on the rise, reflecting a shift towards more personalized and accessible healthcare.
  3. Impact of Comorbidities on Hypertension Outcomes:
    Increasing attention is being paid to how conditions such as diabetes, obesity, and sleep apnea interact with hypertension, emphasizing the need for comprehensive management strategies.
  4. Artificial Intelligence and Machine Learning Applications:
    The application of AI and machine learning in predicting hypertension outcomes and personalizing treatment plans is an emerging area of interest, reflecting advancements in technology.
  5. Longitudinal Studies and Clinical Trials:
    An increase in long-term studies evaluating the outcomes of hypertension interventions, including pharmacological treatments and lifestyle changes, is evident, providing richer data for clinical practice.

Declining or Waning

Over the recent years, certain themes in 'Clinical Hypertension' have shown a decline in publication frequency or relevance. This section highlights those areas that are becoming less prominent in the journal's focus.
  1. Traditional Lifestyle Interventions:
    Research on basic lifestyle interventions, such as simple dietary recommendations, has seen a reduction as more complex and multifaceted approaches gain interest.
  2. Single-Factor Risk Assessments:
    Studies focusing solely on individual risk factors for hypertension without considering their interactions or the broader context of comorbidities are becoming less common.
  3. General Hypertension Awareness Campaigns:
    While public health campaigns remain important, there is a noticeable shift towards more specific, targeted studies that assess the impact of these campaigns rather than general awareness.

Similar Journals

AMERICAN JOURNAL OF HYPERTENSION

Pioneering insights into hypertension management.
Publisher: OXFORD UNIV PRESSISSN: 0895-7061Frequency: 12 issues/year

American Journal of Hypertension, published by Oxford University Press, is a leading peer-reviewed journal dedicated to the field of hypertension and cardiovascular health. With an ISSN of 0895-7061 and an E-ISSN of 1941-7225, this prestigious journal has been providing researchers and clinicians with significant advancements in hypertension research since its inception in 1954, with a continued focus on innovative studies through 2024. Ranked Q2 in Internal Medicine and positioned within the top 22% of its category according to Scopus, it is a vital resource for those involved in clinical practice and research aimed at understanding and managing hypertension. The journal disseminates pivotal findings, treatment updates, and guideline recommendations that contribute to improved patient care globally. Accessible solely through subscription, the American Journal of Hypertension is essential reading for professionals committed to enhancing cardiovascular health outcomes.

Integrated Blood Pressure Control

Advancing Blood Pressure Management for Better Health
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7104Frequency: 1 issue/year

Integrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.

Journal of Nutrition and Metabolism

Exploring the Intersection of Nutrition and Metabolic Health
Publisher: HINDAWI LTDISSN: 2090-0724Frequency: 1 issue/year

Journal of Nutrition and Metabolism, published by HINDAWI LTD, is a prominent peer-reviewed, open-access journal that has been serving the scientific community since 2010. Based in Egypt, this journal is dedicated to advancing the field of nutrition and metabolism, providing a platform for innovative research that spans endocrinology, diabetes, food science, and dietetics. With a consistent commitment to accessibility, it embraces open-access policies to facilitate wider dissemination of knowledge, ensuring that researchers, professionals, and students can freely engage with pivotal studies and findings. The journal is currently indexed with an impressive standing in various categories, including being positioned in Q2 in Food Science and Q3 in Endocrinology, Diabetes and Metabolism. Furthermore, it ranks among the top journals in its fields on Scopus, reflecting its significance and impact within the research community. With a focus on robust, evidence-based studies that inform dietary practices and metabolic health, the Journal of Nutrition and Metabolism plays a crucial role in addressing the challenges of modern nutrition.

Journal fur Hypertonie

Pioneering insights into the complexities of hypertension.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1028-2327Frequency: 2 issues/year

Journal fur Hypertonie is a leading academic journal published by KRAUSE & PACHERNEGG GMBH, dedicated to the critical field of hypertension research. Since its inception in 1998, the journal has served as a vital platform for disseminating pioneering studies and advancements in the diagnosis, treatment, and management of hypertension. Although its Scopus coverage was discontinued in 2016, the journal continues to hold significance within the academic community, evidenced by its ranking of #98 out of 124 in Internal Medicine, placing it in the 21st percentile. This reflects its targeted impact and relevance in the evolving landscape of cardiovascular research. With no Open Access options, the journal remains a specialized resource indispensable for researchers, healthcare professionals, and students focused on enhancing their understanding and clinical practices related to hypertension. The journal's address is MOZARTGASSE 10, GABLITZ 3003, AUSTRIA.

HYPERTENSION

Exploring the forefront of hypertension science.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0194-911XFrequency: 12 issues/year

HYPERTENSION, published by Lippincott Williams & Wilkins, is a preeminent journal in the field of cardiovascular medicine, focusing on the latest research, therapies, and clinical practices related to hypertension and its associated disorders. With a distinguished Q1 ranking in Internal Medicine and a commendable Scopus rank of #12 out of 167 in its category, it occupies a vital position within the academic community, appealing to researchers, clinicians, and educators alike. The journal has been disseminating impactful findings since 1979 and continues to influence the discourse on hypertension through rigorous peer-reviewed articles, reviews, and studies designed to elevate understanding and treatment of this prevalent condition. HYPERTENSION remains an essential resource for professionals keen on advancing their knowledge in this critical area of medicine, fostering innovations that ultimately improve patient care.

HYPERTENSION IN PREGNANCY

Bridging Research and Practice in Hypertension Management
Publisher: TAYLOR & FRANCIS INCISSN: 1064-1955Frequency: 3 issues/year

HYPERTENSION IN PREGNANCY is a leading academic journal dedicated to the critical study of hypertensive disorders during pregnancy, a crucial area of maternal and fetal health. Published by Taylor & Francis Inc, this journal boasts an Open Access policy since 2023, ensuring that research findings are freely accessible to a global audience. With an ISSN of 1064-1955 and E-ISSN of 1525-6065, it offers a platform for high-quality research and review articles since its inception in 1982. The journal holds a Q3 category ranking in both Internal Medicine and Obstetrics and Gynecology, reflecting its reputable standing within the scientific community. As of 2023, it ranks among the top quartile publications in its field, with Scopus ranking it 86/209 in Obstetrics and Gynecology and 83/167 in Internal Medicine. This journal aims to foster dialogue among researchers, clinicians, and policymakers regarding the management and implications of hypertension in pregnancy, promoting advancements in care and research methodologies. Located in Philadelphia, PA, it continues to be an invaluable resource for those invested in improving maternal health outcomes and advancing the field.

KIDNEY & BLOOD PRESSURE RESEARCH

Pioneering Research for a Healthier Tomorrow.
Publisher: KARGERISSN: 1420-4096Frequency: 12 issues/year

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

JOURNAL OF HYPERTENSION

Your premier source for cutting-edge cardiovascular research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0263-6352Frequency: 12 issues/year

JOURNAL OF HYPERTENSION, published by Lippincott Williams & Wilkins, stands at the forefront of cardiovascular research, serving as a premier platform for the dissemination of knowledge in hypertension and related cardiovascular conditions. With an impressive impact factor, this esteemed journal is recognized in Q1 quartile across multiple categories, including Cardiology, Internal Medicine, and Physiology as of 2023, firmly establishing its significance within the academic community. The journal has been a reliable source of cutting-edge research since its inception in 1983, with continued publication through 2024. Researchers can expect a rigorous peer-review process and a diverse array of articles that include original research, reviews, and clinical studies aimed at enhancing the understanding and management of hypertension. Although it is not an open-access journal, the JOURNAL OF HYPERTENSION remains invaluable to clinicians, researchers, and students dedicated to advancing the field of cardiovascular health.

BLOOD PRESSURE

Unveiling the latest in blood pressure-related research.
Publisher: TAYLOR & FRANCIS LTDISSN: 0803-7051Frequency: 6 issues/year

BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.

Cerebral Circulation-Cognition and Behavior

Illuminating the Pathways of Thought and Behavior
Publisher: ELSEVIERISSN: 2666-2450Frequency: 1 issue/year

Cerebral Circulation-Cognition and Behavior is an impactful journal published by Elsevier that focuses on the intersections of cerebral circulation, cognitive function, and behavioral science. Since its establishment in 2020, the journal has provided a vital platform for researchers and professionals in the fields of Behavioral Neuroscience, Biological Psychiatry, and Cognitive Neuroscience. With a current classification in the Q3 quartile across several neuroscience categories and a promising trajectory during its converged years (2020-2024), the journal highlights significant advancements in our understanding of the neural underpinnings of behavior. Although it is not open access, its commitment to quality research makes it an essential resource for anyone engaged in neurological, cognitive, and psychiatric studies. As discoveries in these fields continue to grow, Cerebral Circulation-Cognition and Behavior remains dedicated to disseminating influential findings that bridge the gap between cognition, behavior, and neural health.